STAAR Surgical Investor Broadwood Partners Says Alcon's Proposed Acquisition Remains 'Unfair' to Shareholders

MT Newswires Live12-11

STAAR Surgical (STAA) investor Broadwood Partners, which owns a 30.2% stake in the company, said Thursday that the proposed acquisition of the company by Alcon (ALC) remains "unfair" to shareholders.

Noting that a member of the STAAR Surgical's board recently voted against the transaction in a boardroom vote, Broadwood Partners said that the director joins the list of shareholders and proxy advisory firms who have showed concerns about the deal process, timing, and price.

Broadwood Partners said that most recently a majority of the company's board approved the revised deal terms without seeking an updated fairness opinion from the board's financial advisor.

STAAR Surgical did not immediately respond to MT Newswires' request for comment.

Shares of the company were up 3.7% in early Thursday trading.

Price: 24.90, Change: +0.91, Percent Change: +3.79

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment